•Reporting to CFO, instituted and lead all budgeting/forecasting across $90+M revenue and >$100M OpEx for SaaS and genomics sequencing businesses, driving both executive management and departmental heads towards financial goals.•Drive financial process/reporting innovation while simultaneously streamlining and standardizing departmental, annual and long range planning (covering revenue, opex, and capex).•Strong business partner and deep understanding of operations. Established functional and product based KPI's/metrics helping to drive operational efficiency and bottom-line gains. •Partnering with Sales and Marketing, overseeing bookings/revenue forecasting and metric evaluation•Lead the treasury function, managing all aspects of A/R and A/P. Evolved cash management through system, personnel and process improvements •Working directly with Strategy and Product teams, oversee financial business case development, covering both internal valuations and M&A activity •Manage development of key quarterly and annual reporting metrics/presentations including earnings calls, audit committee presentations and management team meetings•Extensive interaction with executive management, CFO, Controller and functional business leaders to support GAAP financial statements and SEC filings/projects (e.g. ASC 606, ASC 842)

•Reporting to CFO, developed and managed all FP&A activities for 10+ subsidiaries across biotech, genomic sequencing and medical device sectors. •Created budget/forecast process, drove financial system (Hyperion) implementation, and developed strong relationships with departmental leaders•Developed clinical trial budget via significant interaction with Clinical Operations/R&D functions•Created drug costing and strategic manufacturing network NPV analysis, leveraging the Mfg and R&D orgs.•Supported all relevant M&A activity, working with both internal and external resources to drive analysis

Lead Operations Finance Business Analysis team, overseeing business development and internal valuation support for marketed products with $20B+ in sales and 20+ pipeline products. Direct NPV, cost of sales, and manufacturing strategy analysis for Operations/Finance leadership.Operations finance lead for Business Development (in/out licensing and acquisitions) - support cost of goods sold analysis, manufacturing site cost/benefits, and product life cycle management modeling. Managed Operations finance diligence and analysis of $1.25B acquisition of Dezima Pharma and 3 other $100M+ transactions. Oversee diligence of 20+ transactions per year.

Direct all supply planning, in-country distribution, product launches and manufacturing variation implementation for the Amgen Brazil affiliate.• Manage supply planning across six products and three manufacturing sites (including 2 CMO’s). Drive cross-functional coordination between Commercial, Regulatory, Quality and Sites to establish two to three year supply plan.• Strong relationship with local and regional Commercial organizations to understand short and long term forecast and associated drivers. Manage monthly S&OP process and meetings to ensure cross-functional alignment.• Led development and on-time startup of logistics service provider (DHL) in Brazil. Significant cross-company management, process development, and tactical distribution capability setup required.• Supervise LSP operations and drive implementation of Amgen distribution processes within Brazil. Includes LSP management, security, returns, importation, and operational excellence initiatives.• Directed setup and launch of Neupogen/Neulasta into existing Amgen Brazil operations. Managed complex supply planning and buyback process between Amgen and Roche to ensure continued supply during transition. • Coordinated supply and launch of Nplate in Q1’13 and currently engaged for setup and subsequent launch of Aranesp in Q1’15. • In conjunction with Commercial forecasts, leverage strong relationships with Sites and Regulatory to ensure seamless introduction of manufacturing variations into supply planning.

Managed and implemented cross-regional strategic planning and operational excellence projects and drove emerging market commercialization efforts within Supply Chain• Leveraging lean/6 sigma applications, managed global assessment of distribution non-conformances resulting in identification of over $1MM in savings opportunities. • Managed development and implementation of the Emerging Market Risk Assessment Tool. Employed for business case and commercialization processes involving emerging market entry. Significant cross-functional coordination (Supply Chain, Regulatory, Commercial, Quality)• Developed dynamic resource model for Alliance Management, Latin America and Canadian Supply Chain organizations. Latin American model utilized in development of region’s overall strategic plan for 2020.• Lead team composing all Amgen sites, regulatory, quality and supply chain, which constructed a FDP/DS Sample and QC Material forecast for emerging markets. Significant reduction in turn-around time and site burden.• Directed development of key Supply Chain growth and complexity metrics utilized for long-term strategic planning• Constructed cost model detailing incremental costs attributable to Operations due to new market entry. Directed core team and employed data points across numerous functions within Operations

Operations distribution strategyContract optimization

Developed strategy for transferring drug production from an international contract manufacturer to in-house facilities.Lead cross-functional team to conduct financial, operational and strategic assessments of transfer. Employed tax implication, risk mitigation, and NPV analysis to drive the strategy's analytical foundation, resulting in $6MM savings and significant risk mitigation.Presented recommended transfer strategy to senior management.

Guided market research to evaluate investment bank partnerships and potential acquisitions for a middle-market private equity firm.Constructed database of key valuation metrics for potential acquisition targets and developed relationships with desired targets.Worked with team members to perform research and valuation for potential acquisitions.

Directed engineering safety analysis projects for multi-national clients in the petroleum, chemical manufacturing, and power generation industries. Managed team of engineers to develop, market, and implement new product lines in liquefied natural gas, explosion modeling, bio-fuel and electrochemical plating. Managed and led over 15 engineering safety analysis projects for multi-national firms such as Total and Saudi International Petrochemical Company. Studies included teams of over 20 engineers, health inspectors, and management in locations across the United States, Canada, and the Caribbean.Developed and marketed new dispersion modeling services for U.S. based refineries, resulting in two new clients and $30K in new net revenue. Directed marketing team in evaluating and increasing exposure in liquefied natural gas (LNG), bio-fuel, and metal plating markets. Obtained 5 clients resulting in over $100K of new net revenue.Developed and negotiated budget proposals, established project schedule, and resourced staffing for over 10 clients and $200K in revenue.